Literature DB >> 9767060

Management of infections due to antibiotic-resistant Streptococcus pneumoniae.

S L Kaplan1, E O Mason.   

Abstract

Antibiotic-resistant strains of Streptococcus pneumoniae are becoming more prevalent throughout the world; this has resulted in modifications of treatment approaches. Management of bacterial meningitis has the greatest consensus. Strategies for treating other systemic infections such as pneumonia, bacteremia, and musculoskeletal infections are evolving, in part related to the availability of new antibiotics which are active in vitro against isolates resistant to penicillin and the extended-spectrum cephalosporins. However, there are currently very limited data related to the clinical efficacy of these new agents. The studies upon which current recommendations are based are reviewed. Otitis media represents the single most common infection due to S. pneumoniae. Recommendations for treatment of acute otitis media due to drug-resistant strains and the rationale for these recommendations are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9767060      PMCID: PMC88901          DOI: 10.1128/CMR.11.4.628

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  132 in total

Review 1.  Pharmacokinetics and pharmacodynamics of antibiotics in otitis media.

Authors:  W A Craig; D Andes
Journal:  Pediatr Infect Dis J       Date:  1996-03       Impact factor: 2.129

2.  Serum protein binding and extravascular diffusion of methoxyimino cephalosporins. Time courses of free and total concentrations of cefotaxime and ceftriaxone in serum and pleural exudate.

Authors:  F Scaglione; M Raichi; F Fraschini
Journal:  J Antimicrob Chemother       Date:  1990-09       Impact factor: 5.790

3.  Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae.

Authors:  Y S Kim; Q Liu; L L Chow; M G Täuber
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

4.  Comparison of ceftriaxone and trimethoprim-sulfamethoxazole for acute otitis media. Greater Boston Otitis Media Study Group.

Authors:  E D Barnett; D W Teele; J O Klein; H J Cabral; S J Kharasch
Journal:  Pediatrics       Date:  1997-01       Impact factor: 7.124

5.  Resistance to penicillin and non-beta-lactam antibiotics of Streptococcus pneumoniae at a children's hospital.

Authors:  P L Welby; D S Keller; J L Cromien; P Tebas; G A Storch
Journal:  Pediatr Infect Dis J       Date:  1994-04       Impact factor: 2.129

6.  Consensus report: antimicrobial therapy for bacterial meningitis in infants and children.

Authors:  G H McCracken; J D Nelson; S L Kaplan; G D Overturf; W J Rodriguez; R W Steele
Journal:  Pediatr Infect Dis J       Date:  1987-06       Impact factor: 2.129

7.  Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease.

Authors:  I R Friedland
Journal:  Pediatr Infect Dis J       Date:  1995-10       Impact factor: 2.129

8.  Persistent acute otitis media: I. Causative pathogens.

Authors:  M E Pichichero; C L Pichichero
Journal:  Pediatr Infect Dis J       Date:  1995-03       Impact factor: 2.129

9.  Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae.

Authors:  M J Catalán; J M Fernández; A Vazquez; E Varela de Seijas; A Suárez; J C Bernaldo de Quirós
Journal:  Clin Infect Dis       Date:  1994-05       Impact factor: 9.079

10.  Risk/benefit in the treatment of children with imipenem-cilastatin for meningitis caused by penicillin-resistant pneumococcus.

Authors:  F Asensi; M C Otero; D Pérez-Tamarit; I Rodríguez-Escribano; J L Cabedo; S Gresa; E Cantón
Journal:  J Chemother       Date:  1993-04       Impact factor: 1.714

View more
  53 in total

1.  Two-year surveillance of antibiotic resistance in Streptococcus pneumoniae in four African cities.

Authors:  M Benbachir; S Benredjeb; C S Boye; M Dosso; H Belabbes; A Kamoun; O Kaire; N Elmdaghri
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Role of global surveillance in combating bacterial resistance.

Authors:  A Marchese; G C Schito
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Serotype 19f multiresistant pneumococcal clone harboring two erythromycin resistance determinants (erm(B) and mef(A)) in South Africa.

Authors:  L McGee; K P Klugman; A Wasas; T Capper; A Brink
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

4.  Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievable in cerebrospinal fluid.

Authors:  F Fitoussi; C Doit; P Geslin; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

5.  Impact of Antimicrobial Resistance on the Treatment of Invasive Pneumococcal Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

6.  Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.

Authors:  J G Bartlett; S F Dowell; L A Mandell; T M File; D M Musher; M J Fine
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

Review 7.  Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions.

Authors:  S J Schrag; B Beall; S F Dowell
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

8.  Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

Authors:  G V Doern; K P Heilmann; H K Huynh; P R Rhomberg; S L Coffman; A B Brueggemann
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

9.  Usefulness of urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal pneumonia in children.

Authors:  J Domínguez; S Blanco; C Rodrigo; M Azuara; N Galí; A Mainou; A Esteve; A Castellví; C Prat; L Matas; V Ausina
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

10.  Role of HtrA in the virulence and competence of Streptococcus pneumoniae.

Authors:  Yasser Musa Ibrahim; Alison R Kerr; Jackie McCluskey; Tim J Mitchell
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.